HU0302830D0 - Transdermal drug delivery by means of chemical pressure - Google Patents
Transdermal drug delivery by means of chemical pressureInfo
- Publication number
- HU0302830D0 HU0302830D0 HU0302830A HUP0302830A HU0302830D0 HU 0302830 D0 HU0302830 D0 HU 0302830D0 HU 0302830 A HU0302830 A HU 0302830A HU P0302830 A HUP0302830 A HU P0302830A HU 0302830 D0 HU0302830 D0 HU 0302830D0
- Authority
- HU
- Hungary
- Prior art keywords
- drug delivery
- transdermal drug
- chemical pressure
- chemical
- pressure
- Prior art date
Links
- 239000000126 substance Substances 0.000 title 1
- 238000013271 transdermal drug delivery Methods 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0302830A HUP0302830A2 (en) | 2003-09-02 | 2003-09-02 | Transdermal drug formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0302830A HUP0302830A2 (en) | 2003-09-02 | 2003-09-02 | Transdermal drug formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
HU0302830D0 true HU0302830D0 (en) | 2003-10-28 |
HUP0302830A2 HUP0302830A2 (en) | 2005-05-30 |
Family
ID=89981615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0302830A HUP0302830A2 (en) | 2003-09-02 | 2003-09-02 | Transdermal drug formulation |
Country Status (1)
Country | Link |
---|---|
HU (1) | HUP0302830A2 (en) |
-
2003
- 2003-09-02 HU HU0302830A patent/HUP0302830A2/en active IP Right Revival
Also Published As
Publication number | Publication date |
---|---|
HUP0302830A2 (en) | 2005-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1252167A1 (en) | Liposomes useful for drug delivery | |
IL174894A0 (en) | Transdermal drug delivery device | |
EP1802258A4 (en) | Biosynchronous transdermal drug delivery | |
IL181555A0 (en) | Method of assembly of drug delivery devices | |
EP1737879A4 (en) | Aptamer-mediated intracellular delivery of therapeutic oligonucleotides | |
EP1909772A4 (en) | Transdermal drug delivery formulation | |
IL174690A0 (en) | Enhanced drug delivery | |
AU2003221770A8 (en) | Controlled release transdermal drug delivery | |
IL175878A0 (en) | Transdermal system for sustained delivery of polypeptides | |
HK1095082A1 (en) | Form of administration secured against misuse | |
EP1681069A4 (en) | Medicinal liquid infusion apparatus | |
EP1781355A4 (en) | Drug delivery device | |
EP1796676A4 (en) | Transdermal administration of phycotoxins | |
HK1074801A1 (en) | Transdermal delivery system of gestodene | |
GB2400565B (en) | Nasal drug delivery | |
EP1810706A4 (en) | Medicinal liquid infusion apparatus | |
AU2003212962A8 (en) | Transdermal drug delivery systems | |
EP1791506A4 (en) | Methods of device-assisted drug delivery | |
HU0302830D0 (en) | Transdermal drug delivery by means of chemical pressure | |
GB0327742D0 (en) | Novel uses of known drugs | |
GB0313748D0 (en) | Drug delivery compounds | |
GB0413234D0 (en) | Drug delivery compounds | |
GB0329141D0 (en) | Drug delivery | |
GB0311084D0 (en) | Drug delivery | |
GB0329041D0 (en) | Nasal drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees | ||
NF4A | Restoration of patent protection | ||
FD9A | Lapse of provisional protection due to non-payment of fees |